• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用聚合酶链反应对非HIV感染的免疫功能低下患者进行卡氏肺孢子虫肺炎筛查。

Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction.

作者信息

Jiancheng Wang, Minjun Huang, Yi-jun An, Lan Sun, Zengzhu Guo, Jianrong Su, Xixiong Kang

机构信息

Beijing Tropical Medicine Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

出版信息

Diagn Microbiol Infect Dis. 2009 Aug;64(4):396-401. doi: 10.1016/j.diagmicrobio.2009.04.009.

DOI:10.1016/j.diagmicrobio.2009.04.009
PMID:19631093
Abstract

We evaluated the clinical value of polymerase chain reaction (PCR) for screening Pneumocystis carinii pneumonia (PCP) in non-HIV-infected immunocompromised patients. We retrospectively analyzed PCR and Grocott's methenamine silver (GMS) staining on 1044 clinical specimens obtained from 756 patients. Positive rates of PCR and GMS staining in sputum specimens were 21.1% and 9.5%, respectively (P < 0.01), and in bronchoalveolar lavage (BAL), specimens were 31.9% and 25.5%, respectively. Among 5 patient groups, the highest GMS staining and PCR positive rates were observed in immunosuppressed patients. In 28 GMS staining-positive patients, positive rates of PCR and GMS staining after a short anti-PCP treatment were 39.3% and 17.9%, respectively. In 5 patients with positive PCR but negative GMS staining results in initial sputum examination, GMS staining result turned positive in subsequent BAL specimens. In conclusion, PCR is sensitive for detection of Pneumocystis in sputum specimens and is useful for screening PCP in non-HIV-infected high-risk patients.

摘要

我们评估了聚合酶链反应(PCR)在筛查非HIV感染的免疫功能低下患者卡氏肺孢子虫肺炎(PCP)中的临床价值。我们回顾性分析了从756例患者获取的1044份临床标本的PCR及格罗科特六胺银(GMS)染色结果。痰标本中PCR和GMS染色的阳性率分别为21.1%和9.5%(P<0.01),支气管肺泡灌洗(BAL)标本中分别为31.9%和25.5%。在5个患者组中,免疫抑制患者的GMS染色和PCR阳性率最高。在28例GMS染色阳性患者中,短程抗PCP治疗后PCR和GMS染色的阳性率分别为39.3%和17.9%。在5例初始痰检PCR阳性但GMS染色阴性的患者中,后续BAL标本的GMS染色结果转为阳性。总之,PCR对痰标本中肺孢子虫的检测敏感,有助于筛查非HIV感染的高危患者中的PCP。

相似文献

1
Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction.使用聚合酶链反应对非HIV感染的免疫功能低下患者进行卡氏肺孢子虫肺炎筛查。
Diagn Microbiol Infect Dis. 2009 Aug;64(4):396-401. doi: 10.1016/j.diagmicrobio.2009.04.009.
2
Laboratory diagnosis and occurrence of Pneumocystis carinii.卡氏肺孢子虫的实验室诊断与发病情况
Scand J Infect Dis Suppl. 1994;94:1-34.
3
A clinical comparative study of polymerase chain reaction assay for diagnosis of pneumocystis pneumonia in non-AIDS patients.非艾滋病患者肺孢子菌肺炎聚合酶链反应诊断的临床对比研究。
Chin Med J (Engl). 2011 Sep;124(17):2683-6.
4
PCR diagnosis of Pneumocystis carinii on sputum and bronchoalveolar lavage samples in immuno-compromised patients.免疫功能低下患者痰液和支气管肺泡灌洗样本中卡氏肺孢子虫的PCR诊断
Parasitol Res. 2004 Oct;94(3):213-8. doi: 10.1007/s00436-004-1200-y. Epub 2004 Sep 1.
5
[Comparison of the methenamine silver staining, direct fluorescent antibody and nested-polymerase chain reaction methods in the diagnosis of Pneumocystis carinii pneumonia].[甲胺银染色、直接荧光抗体法和巢式聚合酶链反应法在卡氏肺孢子虫肺炎诊断中的比较]
Mikrobiyol Bul. 2004 Jan-Apr;38(1-2):105-12.
6
Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: a blinded comparison to standard methods.用聚合酶链反应诊断人类免疫缺陷病毒感染患者的卡氏肺孢子虫肺炎:与标准方法的盲法比较
Clin Infect Dis. 2000 Jan;30(1):141-5. doi: 10.1086/313584.
7
Direct monitoring as well as sensitive diagnosis of Pneumocystis carinii pneumonia by the polymerase chain reaction on sputum samples.通过对痰液样本进行聚合酶链反应,对卡氏肺孢子虫肺炎进行直接监测以及灵敏诊断。
Mol Cell Probes. 1993 Dec;7(6):419-24. doi: 10.1006/mcpr.1993.1062.
8
Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.免疫功能低下患者耶氏肺孢子菌肺炎的分子诊断
Mycoses. 2010 Jul;53(4):329-33. doi: 10.1111/j.1439-0507.2009.01715.x. Epub 2009 Jun 1.
9
Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases.通过DNA扩增检测结缔组织病患者中的卡氏肺孢子菌:对风湿性疾病中卡氏肺孢子菌肺炎临床特征的重新评估。
Rheumatology (Oxford). 2004 Apr;43(4):479-85. doi: 10.1093/rheumatology/keh071. Epub 2004 Feb 3.
10
Evaluation of Toluidine Blue O staining for the diagnosis of Pneumocystis jiroveci in expectorated sputum sample and bronchoalveolar lavage from HIV-infected patients in a tertiary care referral center in Ethiopia.在埃塞俄比亚一家三级医疗转诊中心,对甲苯胺蓝O染色法在诊断HIV感染患者咳出痰液样本和支气管肺泡灌洗样本中的耶氏肺孢子菌的应用进行评估。
Infection. 2008 Jun;36(3):237-43. doi: 10.1007/s15010-007-7191-8. Epub 2008 May 15.

引用本文的文献

1
pneumonia in people living with HIV: a review.HIV 感染者肺炎:综述。
Clin Microbiol Rev. 2024 Mar 14;37(1):e0010122. doi: 10.1128/cmr.00101-22. Epub 2024 Jan 18.
2
Diagnosis of invasive fungal infections: challenges and recent developments.侵袭性真菌感染的诊断:挑战与新进展。
J Biomed Sci. 2023 Jun 19;30(1):42. doi: 10.1186/s12929-023-00926-2.
3
Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.诊断耶氏肺孢子菌肺炎:当前方法与新途径综述
Med Mycol. 2020 Nov 10;58(8):1015-1028. doi: 10.1093/mmy/myaa024.
4
Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer.肺癌患者肺孢子菌肺炎的危险因素和临床特征。
Sci Rep. 2019 Feb 14;9(1):2094. doi: 10.1038/s41598-019-38618-3.
5
Role of Pneumocystis jirovecii in patients with different pulmonary underlying condition using a nested-PCR.采用巢式聚合酶链反应研究耶氏肺孢子菌在不同肺部基础疾病患者中的作用。
Rev Esp Quimioter. 2018 Aug;31(4):336-343. Epub 2018 Jun 29.
6
Low Titer Pneumocystis jirovecii Infections: More than Just Colonization?低滴度耶氏肺孢子菌感染:仅仅是定植吗?
J Fungi (Basel). 2016 May 28;2(2):16. doi: 10.3390/jof2020016.
7
Diagnosis of pneumonia with serum cell-free DNA in non-HIV-infected immunocompromised patients.非HIV感染免疫功能低下患者血清游离DNA对肺炎的诊断
Oncotarget. 2017 May 20;8(42):71946-71953. doi: 10.18632/oncotarget.18037. eCollection 2017 Sep 22.
8
Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.肾移植受者肺孢子菌肺炎(PJP)的危险因素。
Sci Rep. 2017 May 8;7(1):1571. doi: 10.1038/s41598-017-01818-w.
9
Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak.肾移植中肺孢子菌肺炎的管理以预防进一步爆发
Clin Med Insights Circ Respir Pulm Med. 2015 Nov 15;9(Suppl 1):81-90. doi: 10.4137/CCRPM.S23317. eCollection 2015.
10
dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with pneumonia.一组HIV阴性免疫功能低下肺炎患者的二氢蝶酸合酶基因突变
Exp Ther Med. 2014 Dec;8(6):1825-1830. doi: 10.3892/etm.2014.2002. Epub 2014 Oct 3.